Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection
about
Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic MiceAntiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirusIL-33 induces nuocytes and modulates liver injury in viral hepatitis.Immune effectors required for hepatitis B virus clearanceAn intradermal environment promotes a protective type-1 response against lethal systemic monocytotropic ehrlichial infectionSusceptibility to acetaminophen (APAP) toxicity unexpectedly is decreased during acute viral hepatitis in mice.Cytotoxic effector function of CD4-independent, CD8(+) T cells is mediated by TNF-α/TNFR.Intrahepatic lymphocyte expression of dipeptidyl peptidase I-processed granzyme B and perforin induces hepatocyte expression of serine proteinase inhibitor 6 (Serpinb9/SPI-6).The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B-dependent hepatotoxicity.Novel Immunotherapies for Autoimmune Hepatitis.The role of intrahepatic CD3+/CD4-/CD8- double negative T (DN T) cells in enhanced acetaminophen toxicity.Role of the perforin/granzyme cell death pathway in D-Gal/LPS-induced inflammatory liver injury.Fas Ligand localizes to intraluminal vesicles within NK cell cytolytic granules and is enriched at the immune synapse.Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis
P2860
Q27489517-2042EFD5-A78D-4FCC-9DD1-DFEF44FBBB2AQ28221835-8323755D-E204-4009-8189-FD51D89D89FDQ28588039-7F15C3B8-73FB-4792-8F10-BEE73D14BA3BQ33640225-39314C56-CEE4-4BAA-87C4-12A4B5A8F490Q34975715-56A6509D-D6DC-487B-A826-43405B49C208Q35080126-F4931B9F-99E1-4E35-B2AB-AD7376A8A038Q36468274-123127D3-C43D-4B8E-8F96-59B3613D334CQ37124811-B20CAD50-1B8B-4D2B-91CE-6C312125E65FQ37137513-7B7D3948-99D9-477A-B206-3964B5DCB928Q37607111-EE3DF175-19DF-4E44-9F51-9454F989B2A1Q42704352-0ACFAF7A-4935-46EE-80D6-F04FDDD1BDBDQ44902660-36537461-3BCA-4F8B-9C94-BCA3DE222F55Q55284675-EECE0775-B247-43AB-9B2F-0BAD36512DD6Q59136675-3125E3F0-A1F7-4E71-909A-CB244CE85778
P2860
Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fas and TNFR1, but not cytolyt ...... ine liver adenoviral infection
@en
Fas and TNFR1, but not cytolyt ...... ne liver adenoviral infection.
@nl
type
label
Fas and TNFR1, but not cytolyt ...... ine liver adenoviral infection
@en
Fas and TNFR1, but not cytolyt ...... ne liver adenoviral infection.
@nl
prefLabel
Fas and TNFR1, but not cytolyt ...... ine liver adenoviral infection
@en
Fas and TNFR1, but not cytolyt ...... ne liver adenoviral infection.
@nl
P2093
P2860
P356
P1433
P1476
Fas and TNFR1, but not cytolyt ...... ine liver adenoviral infection
@en
P2093
Bonnie C Miller
David K Spady
Dwain L Thiele
Marwan S Abougergi
Sarah J Gidner
P2860
P304
P356
10.1002/HEP.20504
P407
P577
2005-01-01T00:00:00Z